Company: Sirtex

Sirtex is a leading biotechnology company based in Singapore, specializing in the development and commercialization of targeted cancer therapies. With a focus on harnessing the power of radiolabeled microspheres, Sirtex aims to improve treatment outcomes for patients with liver cancer and other solid tumors. The company is dedicated to innovative research and strives to provide healthcare professionals with effective tools for cancer management. Committed to enhancing the quality of life for patients, Sirtex continues to expand its global footprint in the oncology market.